Prestige Consumer Healthcare Revenue 2010-2024 | PBH
Prestige Consumer Healthcare revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Prestige Consumer Healthcare Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $1,125 |
| 2023 | $1,128 |
| 2022 | $1,087 |
| 2021 | $943 |
| 2020 | $963 |
| 2019 | $976 |
| 2018 | $1,041 |
| 2017 | $882 |
| 2016 | $806 |
| 2015 | $715 |
| 2014 | $597 |
| 2013 | $620 |
| 2012 | $441 |
| 2011 | $337 |
| 2010 | $293 |
| 2009 | $294 |
| Prestige Consumer Healthcare Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-03-31 | $277 |
| 2023-12-31 | $283 |
| 2023-09-30 | $286 |
| 2023-06-30 | $279 |
| 2023-03-31 | $286 |
| 2022-12-31 | $276 |
| 2022-09-30 | $289 |
| 2022-06-30 | $277 |
| 2022-03-31 | $267 |
| 2021-12-31 | $274 |
| 2021-09-30 | $276 |
| 2021-06-30 | $269 |
| 2021-03-31 | $238 |
| 2020-12-31 | $239 |
| 2020-09-30 | $237 |
| 2020-06-30 | $229 |
| 2020-03-31 | $251 |
| 2019-12-31 | $242 |
| 2019-09-30 | $238 |
| 2019-06-30 | $232 |
| 2019-03-31 | $241 |
| 2018-12-31 | $241 |
| 2018-09-30 | $239 |
| 2018-06-30 | $254 |
| 2018-03-31 | $256 |
| 2017-12-31 | $271 |
| 2017-09-30 | $258 |
| 2017-06-30 | $257 |
| 2017-03-31 | $241 |
| 2016-12-31 | $217 |
| 2016-09-30 | $215 |
| 2016-06-30 | $210 |
| 2016-03-31 | $208 |
| 2015-12-31 | $200 |
| 2015-09-30 | $206 |
| 2015-06-30 | $192 |
| 2015-03-31 | $190 |
| 2014-12-31 | $198 |
| 2014-09-30 | $181 |
| 2014-06-30 | $146 |
| 2014-03-31 | $143 |
| 2013-12-31 | $145 |
| 2013-09-30 | $167 |
| 2013-06-30 | $143 |
| 2013-03-31 | $151 |
| 2012-12-31 | $160 |
| 2012-09-30 | $162 |
| 2012-06-30 | $147 |
| 2012-03-31 | $134 |
| 2011-12-31 | $106 |
| 2011-09-30 | $106 |
| 2011-06-30 | $95 |
| 2011-03-31 | $96 |
| 2010-12-31 | $91 |
| 2010-09-30 | $78 |
| 2010-06-30 | $71 |
| 2010-03-31 | $67 |
| 2009-12-31 | $74 |
| 2009-09-30 | $81 |
| 2009-06-30 | $71 |
| 2009-03-31 | $57 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.449B | $1.125B |
| Prestige Consumer Healthcare Inc. is a consumer healthcare products company. Its diverse portfolio of brands include Monistat(R) and Summer's Eve(R) women's health products, BC(R) and Goody's(R) pain relievers, Clear Eyes(R) and TheraTears(R) eye care products, DenTek(R) specialty oral care products, Dramamine(R) motion sickness treatments, Fleet(R) enemas and glycerin suppositories, Chloraseptic(R) and Luden's(R) sore throat treatments and drops, Compound W(R) wart treatments, Little Remedies(R) pediatric over-the-counter products, Boudreaux's Butt Paste(R) diaper rash ointments, Nix(R) lice treatment, Debrox(R) earwax remover, Gaviscon(R) antacid in Canada, and Hydralyte(R) rehydration products and the Fess(R) line of nasal and sinus care products in Australia. Prestige Consumer Healthcare Inc., formerly known as Prestige Brands Holdings Inc., is based in Tarrytown, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.514B | 24.03 |
| Stryker (SYK) | United States | $129.352B | 30.98 |
| Boston Scientific (BSX) | United States | $113.715B | 36.22 |
| Medtronic (MDT) | Ireland | $103.107B | 15.43 |
| EssilorLuxottica (ESLOY) | France | $101.762B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $40.392B | 0.00 |
| Haleon (HLN) | United Kingdom | $39.132B | 28.57 |
| ResMed (RMD) | United States | $27.007B | 25.36 |
| Terumo (TRUMY) | Japan | $24.269B | 34.27 |
| Koninklijke Philips (PHG) | Netherlands | $23.059B | 18.30 |
| Zimmer Biomet Holdings (ZBH) | United States | $22.264B | 14.22 |
| Baxter (BAX) | United States | $17.305B | 12.30 |
| Insulet (PODD) | United States | $14.411B | 63.90 |
| Demant (WILYY) | Denmark | $10.984B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.877B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.994B | 26.14 |
| BellRing Brands (BRBR) | United States | $7.556B | 35.54 |
| Lantheus Holdings (LNTH) | United States | $5.677B | 14.15 |
| GN Store Nord (GNNDY) | Denmark | $4.364B | 24.51 |
| Haemonetics (HAE) | United States | $4.251B | 20.96 |
| Perrigo (PRGO) | Ireland | $3.490B | 10.58 |
| Neogen (NEOG) | United States | $3.487B | 33.54 |
| TG Therapeutics (TGTX) | United States | $2.966B | 83.43 |
| ICU Medical (ICUI) | United States | $2.799B | 24.70 |
| Envista Holdings (NVST) | United States | $2.750B | 11.35 |
| Green Thumb Industries (GTBIF) | United States | $2.568B | 50.27 |
| Agios Pharmaceuticals (AGIO) | United States | $2.537B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.203B | 12.23 |
| LeMaitre Vascular (LMAT) | United States | $1.838B | 53.87 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.731B | 0.00 |
| Warby Parker (WRBY) | United States | $1.558B | 0.00 |
| InMode (INMD) | Israel | $1.512B | 8.04 |
| AdaptHealth (AHCO) | United States | $1.289B | 9.58 |
| Verano Holdings (VRNOF) | United States | $1.266B | 0.00 |
| Owens & Minor (OMI) | United States | $1.179B | 10.27 |
| AtriCure (ATRC) | United States | $1.013B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.006B | 32.00 |
| BioLife Solutions (BLFS) | United States | $0.984B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.710B | 15.12 |
| PetIQ (PETQ) | United States | $0.656B | 21.21 |
| Evolus (EOLS) | United States | $0.654B | 0.00 |
| Surmodics (SRDX) | United States | $0.598B | 37.46 |
| VAREX IMAGING (VREX) | United States | $0.590B | 13.88 |
| Valneva SE (VALN) | France | $0.520B | 0.00 |
| ZimVie (ZIMV) | United States | $0.495B | 42.21 |
| Canopy Growth (CGC) | Canada | $0.494B | 0.00 |
| Quanterix (QTRX) | United States | $0.485B | 0.00 |
| Biote (BTMD) | United States | $0.449B | 10.33 |
| Jin Medical (ZJYL) | China | $0.432B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.417B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.312B | 10.05 |
| Cerus (CERS) | United States | $0.311B | 0.00 |
| Zynex (ZYXI) | United States | $0.274B | 37.52 |
| MacroGenics (MGNX) | United States | $0.269B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.257B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.247B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.245B | 24.31 |
| Sanara MedTech (SMTI) | United States | $0.243B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.237B | 14.90 |
| Omeros (OMER) | United States | $0.225B | 0.00 |
| High Tide (HITI) | Canada | $0.177B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.155B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.153B | 21.70 |
| TriSalus Life Sciences (TLSI) | United States | $0.151B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.148B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.140B | 67.00 |
| Quipt Home Medical (QIPT) | United States | $0.130B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.126B | 0.00 |
| Veru (VERU) | United States | $0.116B | 0.00 |
| Brainsway (BWAY) | Israel | $0.104B | 0.00 |
| InterCure (INCR) | Israel | $0.099B | 16.77 |
| Fonar (FONR) | United States | $0.099B | 10.00 |
| Cellectar Biosciences (CLRB) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.091B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.090B | 0.00 |
| Chimerix (CMRX) | United States | $0.083B | 0.00 |
| MariMed (MRMD) | United States | $0.072B | 0.00 |
| Bright Green (BGXX) | United States | $0.061B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.059B | 3.86 |
| Safety Shot (SHOT) | United States | $0.054B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.050B | 0.00 |
| Apyx Medical (APYX) | United States | $0.049B | 0.00 |
| United-Guardian (UG) | United States | $0.042B | 15.25 |
| Cytosorbents (CTSO) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.035B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.006B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |